Subject
Gut is a monthly peer-reviewed medical journal on gastroenterology and hepatology. It is the journal of the British Society of Gastroenterology and is published by BMJ. As of 2010, the editor-in-chief is Emad El-Omar. Gut was established in 1960 and covers original research on the gastrointestinal tract, liver, pancreas, and biliary tract. The journal has annual supplements covering the presentations from the British Society of Gastroenterology Annual General Meeting. British Society of Gastroenterology clinical practice guidelines are also published as supplements to the journal. As of March 2010, subscribers to Gut also receive a copy of Frontline Gastroenterology. Source: Wikipedia (en)
Editions published in Gut 200
Too many entities requested (20049). Only 200 are displayed.
-
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
-
Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery
-
The antidiabetic gutsy role of metformin uncovered?
-
The intermediate filament protein, vimentin, is a regulator of NOD2 activity
-
The Oslo definitions for coeliac disease and related terms
-
Intestinal microbiota in functional bowel disorders: a Rome foundation report
-
Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells
-
Guidelines for the management of iron deficiency anaemia
-
Guidelines for the management of inflammatory bowel disease in adults
-
Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease
-
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
-
Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus
-
Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers
-
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
-
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
-
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer
-
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience
-
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
-
Patterns of GI disease in adulthood associated with mutations in the CFTR gene
-
Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease
-
Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides
-
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
-
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
-
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
-
New diagnostic imaging tools for inflammatory bowel disease
-
Recent advances in coeliac disease
-
Guidelines for management of patients with a short bowel
-
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
-
Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency
-
Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas
-
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans
-
Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study
Subject - wd:Q5621669